Hormonal treatment of endometrial cancer

This article summarizes the endocrine background of women with endometrial cancer at both peripheral and tissue levels, and the current status of clin ical trials of hormonal, cytotoxic, and combination regimens. Because signi ficant advances in systemic therapy are required to improve the prognosis o f endometrial cancer, recommendations for future clinical investigations wi ll be based on these recent biologic observations.